News Agency News Aggregator Journalist/Editor Broking House Others
Pfizer, BioNTech say trials find COVID vaccine safe for children of 5-11 yrs
#Pfizer said its #Covid_19 vaccine works for children aged 5 to 11 and that it will seek U.S. authorization for this age group soon - a key step toward beginning vaccinations for youngsters. #Pfizervaccine
Pfizer and BioNTech on Monday said clinical trial results showed their coronavirus vaccine was "safe, well tolerated" and produced a "robust" immune response in children aged five to 11, adding that they would seek regulatory approval shortly
#Pfizer #COVID19 #vaccine
Pfizer and BioNTech’s #COVID-19 vaccine is safe and generates a “robust” immune response in a clinical trial of kids ages 5 to 11, the drugmakers announced in a press release today.
BREAKING: Pfizer says its Covid-19 vaccine is safe and produces strong antibodies in children as young as five years old in a large-scale trial
#Update Food & Drug Administration Advisory Committee has REJECTED a plan to administer BOOSTER SHOTS of Pfizer and BioNTech’s COVID-19 Vaccine to the general public In Friday's Trade .. Pfizer 🔽 1.28% BioNTech 🔽3.6% Moderna 🔽 2.4% @CNBC_Awaaz #AwaazMarke